Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heejoon Jang

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Clinical and Molecular Hepatology|April 28, 2025
Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis BHeejoon Jang, Won Kim
Clinical and Molecular Hepatology|March 9, 2023
Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?Heejoon Jang, Won Kim
Clinical and Molecular Hepatology|June 9, 2025
Reply to correspondence on "Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues"Heejoon Jang, Won Kim
Hepatology (Baltimore, Md.)|September 14, 2022
ReplyHeejoon Jang, Yun Bin Lee, Juneyoung Lee
Kidney Research and Clinical Practice|April 25, 2019
Monitoring globotriaosylsphingosine in a Korean male patient with Fabry diseaseHeejoon Jang, Kwon Wook Joo, Seung Seok Han
Eclinicalmedicine|November 13, 2023
Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort studyJoon Ho Moon, Seogsong Jeong, Heejoon Jang, et al.
Kidney Research and Clinical Practice|September 15, 2017
Heart rate is associated with mortality in patients undergoing continuous renal replacement therapySoojin Lee, Yeonhee Lee, Heejoon Jang, et al.
Liver Cancer|August 8, 2024
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide StudyGi-Ae Kim, Seogsong Jeong, Heejoon Jang, et al.
JAMA Internal Medicine|February 12, 2024
Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver DiseaseHeejoon Jang, Yeonjin Kim, Dong Hyeon Lee, et al.
Alimentary Pharmacology & Therapeutics|May 25, 2026
Risk Prediction of Early-Onset Hepatocellular Carcinoma: Derivation and Validation in a Nationwide Young Adult CohortSeogsong Jeong, Gi-Ae Kim, Heejoon Jang, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Clinical and Molecular Hepatology|April 28, 2025
Type 2 diabetes as a key metabolic risk factor for adverse outcomes in nucleos(t)ide analogue-treated chronic hepatitis BHeejoon Jang, Won Kim
Clinical and Molecular Hepatology|March 9, 2023
Non-obese or lean nonalcoholic fatty liver disease matters, but is it preventable or inevitable in light of its risk factors?Heejoon Jang, Won Kim
Clinical and Molecular Hepatology|June 9, 2025
Reply to correspondence on "Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues"Heejoon Jang, Won Kim
Hepatology (Baltimore, Md.)|September 14, 2022
ReplyHeejoon Jang, Yun Bin Lee, Juneyoung Lee
Kidney Research and Clinical Practice|April 25, 2019
Monitoring globotriaosylsphingosine in a Korean male patient with Fabry diseaseHeejoon Jang, Kwon Wook Joo, Seung Seok Han
Eclinicalmedicine|November 13, 2023
Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort studyJoon Ho Moon, Seogsong Jeong, Heejoon Jang, et al.
Kidney Research and Clinical Practice|September 15, 2017
Heart rate is associated with mortality in patients undergoing continuous renal replacement therapySoojin Lee, Yeonhee Lee, Heejoon Jang, et al.
Liver Cancer|August 8, 2024
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide StudyGi-Ae Kim, Seogsong Jeong, Heejoon Jang, et al.
JAMA Internal Medicine|February 12, 2024
Outcomes of Various Classes of Oral Antidiabetic Drugs on Nonalcoholic Fatty Liver DiseaseHeejoon Jang, Yeonjin Kim, Dong Hyeon Lee, et al.
Alimentary Pharmacology & Therapeutics|May 25, 2026
Risk Prediction of Early-Onset Hepatocellular Carcinoma: Derivation and Validation in a Nationwide Young Adult CohortSeogsong Jeong, Gi-Ae Kim, Heejoon Jang, et al.
Pageof 4